bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47

Genomic analysis of early SARS-CoV-2 strains introduced in Mexico
Blanca Taboada1*, Joel Armando Vazquez-Perez2*, José Esteban Muñoz Medina3*, Pilar Ramos
Cervantes4*, Marina Escalera-Zamudio5*, Celia Boukadida6, Alejandro Sanchez-Flores7, Pavel Isa1, Edgar
Mendieta Condado8, José Arturo Martínez-Orozco2, Eduardo Becerril-Vargas2, Jorge Salas-Hernández2,
Ricardo Grande7, Carolina González-Torres9, Francisco Javier Gaytán-Cervantes9, Gloria Vazquez7,
Francisco Pulido7, Adnan Araiza Rodríguez8, Fabiola Garcés Ayala8, Cesar Raúl González Bonilla10,
Concepción Grajales Muñiz11, Víctor Hugo Borja Aburto12, Gisela Barrera Badillo8, Susana López1, Lucía
Hernández Rivas8, Rogelio Perez-Padilla2, Irma López Martínez8, Santiago Ávila-Ríos6, Guillermo RuizPalacios4, José Ernesto Ramírez-González8+, and Carlos F. Arias1+
1

Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología, Universidad
Nacional Autónoma de México, Cuernavaca, Morelos, Mexico; 2Instituto Nacional de Enfermedades
Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico; 3División de Laboratorios de Vigilancia e
Investigación Epidemiológica, Instituto Mexicano del Seguro Social, Ciudad de México, México; 4Instituto
Nacional de Ciencias Médicas y Nutrición, Ciudad de México, Mexico; 5Department of Zoology, Oxford
University, Oxford, UK; 6Centro de Investigación en Enfermedades Infecciosas, Instituto Nacional de
Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, Mexico; 7Unidad Universitaria de
Secuenciación Masiva y Bioinformática, Instituto de Biotecnología, Universidad Nacional Autónoma de
México, Cuernavaca, Morelos, Mexico; 8Instituto de Diagnóstico y Referencia Epidemiológicos, Dirección
General de Epidemiología, Ciudad de México, Mexico; 9División de Desarrollo de la Investigación,
Instituto Mexicano del Seguro Social, Ciudad de México, México; 10Coordinación de Investigación en
Salud, Instituto Mexicano del Seguro Social, Ciudad de México, México; 11Coordinación de Control
Técnico de Insumos, Instituto Mexicano del Seguro Social, Ciudad de México, México; 12Dirección de
Prestaciones Médicas, Instituto Mexicano del Seguro Social, Ciudad de México, Mexico.

*Blanca Taboada, Joel Armando Vazquez-Perez, José Esteban Muñoz Medina, Pilar Ramos Cervantes,
and Marina Escalera-Zamudio contributed equally to this work
This work is the result of the collaboration of five institutions into one research consortium: three public
health institutes and two universities. From the beginning of this work, it was agreed that the experimental
leader of each institution would share the first authorship. Those were the criteria followed to assign first
co-first authorship in this manuscript. The order of the other authors was randomly assigned.

+Corresponding authors: José Ernesto Ramírez-González, and Carlos F. Arias
JERG: Instituto de Diagnóstico y Referencia Epidemiológicos, Dirección General de Epidemiología,
Ciudad de México, Mexico. e-mail: ernesto.ramirez@salud.gob.mx
CFA: Departamento de Genética del Desarrollo y Fisiología Molecular, Instituto de Biotecnología,
Universidad Nacional Autónoma de México, Cuernavaca, Morelos, Mexico. e-mail: arias@ibt.unam.mx
Running Titer: SARS-CoV-2 genome sequences in Mexico

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

48
49
50

ABSTRACT

51

transmission patterns in different countries is crucial to implement effective strategies for disease control

52

and prevention. In this work, we present the full genome sequence for 17 SARS-CoV-2 isolates

53

corresponding to the earliest sampled cases in Mexico. Global and local phylogenomics, coupled with

54

mutational analysis, consistently revealed that these viral sequences are distributed within 2 known

55

lineages, the SARS-CoV-2 lineage A/G, containing mostly sequences from North America, and the

56

lineage B/S containing mainly sequences from Europe. Based on the exposure history of the cases and

57

on the phylogenomic analysis, we characterized fourteen independent introduction events. Additionally,

58

three cases with no travel history were identified. We found evidence that two of these cases represent

59

local transmission cases occurring in Mexico during mid-March 2020, denoting the earliest events

60

described in the country. Within this Mexican cluster, we also identified an H49Y amino acid change in

61

the spike protein. This mutation is a homoplasy occurring independently through time and space, and

62

may function as a molecular marker to follow on any further spread of these viral variants throughout the

63

country. Our results depict the general picture of the SARS-CoV-2 variants introduced at the beginning of

64

the outbreak in Mexico, setting the foundation for future surveillance efforts.

The COVID-19 pandemic has affected most countries in the world. Studying the evolution and

65
66
67

IMPORTANCE

68

Understanding the introduction, spread and establishment of SARS-CoV-2 within distinct human

69

populations is crucial to implement effective control strategies as well as the evolution of the pandemics.

70

In this work, we describe that the initial virus strains introduced in Mexico came from Europe and the

71

United States and the virus was circulating locally in the country as early as mid-March. We also found

72

evidence for early local transmission of strains having the mutation H49Y in the Spike protein, that could

73

be further used as a molecular marker to follow viral spread within the country and the region.

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

74

INTRODUCTION

75

The 2019 coronavirus disease (COVID-19), declared a pandemic by the WHO on March 11th, 20201, is

76

caused by a novel betacoronavirus known as the severe acute respiratory syndrome coronavirus 2

77

(SARS-CoV-2), detected in December of 2019 in the province of Wuhan in China1. This is the third

78

outbreak related to zoonotic betacoronaviruses known to occur in humans in the last two decades, after

79

SARS (severe acute respiratory syndrome) in 2002 and MERS (Middle East respiratory syndrome) in

80

2012. After its emergence in China, SARS-CoV-2 spread initially to other parts of the world by people with

81

a travel history to China, but gradually shifted to local transmissions2. Viral spread was first detected in

82

Thailand, South Korea and Japan, and by the second half of January, the first positive cases appeared in

83

the USA and Europe (France, Italy and Spain). The current SARS-CoV-2 genome analysis in the

84

Nextstrain site3, points out that viral transmission is now mainly community-driven4,5.

85

In many countries, despite diagnostic efforts and initial control strategies, SARS-CoV-2 spread

86

went on undetected until a critical number of cases requiring hospitalization and intensive care was

87

reached, alerting the authorities in charge. As for May 4th 2020, SARS-CoV-2 has infected more than

88

3,578,000 people and caused around 251,000 deaths worldwide3. In Mexico, the first case of SARS-CoV-

89

2 was detected on February 27th 2020, corresponding to a person who travelled back to Mexico from Italy,

90

and who was in direct contact with a confirmed SARS-CoV-2 case. Soon after, additional cases were

91

detected among travelers that returned from the USA and Europe, increasing every day. By May 4th, there

92

were over 23,400 confirmed cases and 2,150 deaths within the country, indicating local transmission6.

93

Understanding the introduction, spread and establishment of SARS-CoV-2 within distinct human

94

populations is crucial to implement effective control strategies. In this work, we studied the early

95

introduction dynamics of the first SARS-CoV-2 cases in Mexico. For this, we used a whole genome

96

sequencing and phylogenomic approach. We obtained 17 full viral genome sequences, including the first

97

case detected and sampled within the country. Phylogenomic placement showed that these viruses

98

belong to the A2/G and B/S lineages, two of the three circulating viral lineages reported so far. Our

99

analysis also confirms that there have been multiple independent introduction events in Mexico from

100

travelers abroad. We also found evidence for early local transmission of strains having the mutation H49Y

101

in the Spike protein, that could be further used as a molecular marker to follow viral spread within the

102

country.

103

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

104

METHODS

105

Ethical statement

106

All clinical samples were processed at the “Instituto de Diagnóstico y Referencia Epidemiológicos”

107

(InDRE), following official procedures7. All samples used for this work are considered part of the national

108

response to COVID-19, and the data collected is directly related to disease control.

109
110

Sample collection and diagnostics

111

All samples used in this study were collected under the Mexican Official Norm NOM-024-SSA2-1994 for

112

prevention and control of acute respiratory infections in the primary health attention, as part of the early

113

diagnostics scheme for SARS-CoV-2 in public health laboratories and hospitals in Mexico City (Red

114

Nacional de Laboratorios Estatales de Salud Pública, RNLSP; Instituto Nacional de Enfermedades

115

Respiratorias, INER; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, INCMNSZ; and

116

Instituto Mexicano del Seguro Social, IMSS). Oro- and naso-pharyngeal swabs were collected and placed

117

in virus transport medium upon collection, following InDRE official procedures8. A tracheal aspirate was

118

also obtained from one patient and it was frozen at -70oC until use. Diagnosis was done using validated

119

protocols for SARS-CoV 2, as approved by InDRE and by the World Health Organization (WHO)9.

120
121

Sample processing and Whole Genome Sequencing

122

All samples were prepared for RNA extraction, as described10,11. Briefly, centrifuged and filtered

123

supernatants were treated with Turbo DNase and RNAse. Nucleic acids were then extracted using the

124

PureLink™ Viral RNA/DNA Kit (ThermoFisher), following the manufacturer’s instructions and using linear

125

acrylamide (Ambion) as RNA carrier. cDNA was synthesized using the SuperScript III Reverse

126

Transcriptase System (ThermoFisher) and primer A (5’-GTTTCCCAGTAGGTCTCN9-3’). The second

127

strand was generated by two rounds of synthesis with Sequenase 2.0, followed by 15 cycles of

128

amplification using Phusion DNA polymerase using primer B (5’-GTTTCCCAGTAGGTCTC-3). Next,

129

cDNA was purified using the DNA Clean & Concentrator Kit (Zymo Research) and used as input material

130

for generating sequencing libraries, following the Nextera XT DNA Library Preparation Kit12 (Illumina) .

131

Finally, all samples were sequenced on the Illumina NextSeq 500 platform using a 150 cycle High Output

132

Kit v2.5 to obtain paired end reads of 75 base pairs. Sequencing yields are reported in SI Table 1.

133

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

134

Bioinformatic analysis

135

Data quality control and processing

136

Read quality control was carried out using FAST-QC13 under the default parameters. Adapter sequences

137

and low-quality bases were removed using Fastp v0.1914. Low complexity reads, those with a length

138

shorter than 40 bases, and duplicates were excluded using CD-HIT-DUP v.4.6.815. Off-target reads were

139

then filtered out using Bowtie2 v2.3.4.3 with the default parameters against the human genome version

140

GRCh38.p13, and the SILVA database16 as a reference to filter out human DNA and ribosomal

141

sequences.

142
143

Viral genome assembly

144

The reads obtained were used as input to assemble viral genomes using the Wuhan-Hu-1 reference

145

genome sequence (MN908947). For this, the reads obtained for each sample were mapped against the

146

reference using Bowtie2 v2.3.4.3. Aligned reads were then used for de novo assembly using SPAdes v17.

147

Consensus genome sequences were generated using the majority threshold criterion. Only sequences

148

with a coverage above 80% and a mean depth of ≥8X were considered for the analyses (SI Table 1).

149
150

Phylogenetic analyses

151

Data collation

152

From 4698 complete SARS-CoV-2 genomes deposited in the Global Initiative on Sharing All Influenza

153

Data (GISAID) platform on the morning of April 7th 2020, a total of 3014 sequences genomes (>29,000 nt

154

and only high coverage) were downloaded to generate a local database. As the collection dates of the

155

Mexican samples range from late February to March, we filtered sequences collected between

156

02/01/2020 to 03/31/2020 for our database (Table 1). From these, unique sequences were extracted and

157

those identical were collapsed, leaving 2633. We then included the 17 consensus viral genomes

158

determined in this study and the Wuhan-Hu-1 reference genome sequence, yielding a total of 2651

159

sequences. We aligned the whole genome nt dataset using MUSCLE v3.818 under default parameters,

160

and then used the getorfs script from the EMBOSS suite19 to extract complete ORFs (Open Reading

161

Frames) above 300 nt (Orf1a, Orf1b, Spike, M, Orf3a, Orf7a, Orf8 and N), that were then individually re-

162

aligned as described18. Finally, to exclude UTRs and non-coding intergenic regions from the

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

163

phylogenomic analyses, individual ORFs were concatenated to generate an additional 28,320 nt-long

164

whole genome (WG) alignment.

165
166

Data subsampling and tree inference

167

The individual and concatenated alignments were then reversed to nucleotides and used for estimating

168

maximum likelihood (ML) trees using RAxML v820 under the following parameters: -T 2 -f a -x 390 -m

169

GTRGAMMA -p 580 -N 100. All trees were rooted on Wuhan-Hu-1 reference genome sequence21. Given

170

that the SARS-CoV-2 virus shows a low degree of genetic variation22, clade definition must be based on

171

consensus branching patterns within different trees and by shared nucleotide substitution patterns23, in

172

addition to bootstrap support values. Based on these criteria, the position of the Mexican sequences was

173

determined within the whole genome (WG) and individual ORF1a, ORF1b and S trees (SI Table 2), and

174

was then confirmed on the global phylogeny available in Nextstrain24.

175

To visualize details on the phylogenetic relatedness of the Mexican sequences, we then

176

subsampled the previous large-scale WG alignment in a phylogenetically-informed manner, as based on

177

the position of the Mexican strains within the large-scale trees and by selecting sequences using pairwise

178

genetic distances25,26. Briefly, all Mexican sequences were retained together with their immediate

179

ancestors and descendants, and 184 sequences were further selected based on the minor pairwise

180

genetic distance in relation to the Mexican genomes under a threshold of 99.5% (SI Table 3). The

181

subsampled WG alignment was scanned for recombinant sequences using the GARD algorithm27 in the

182

Datamonkey server28,29. A total of 201 sequences, including the Wuhan-Hu-1 reference genome, were

183

used to re-estimate subsampled trees, as described above.

184

Global phylogenetic analysis and shared nucleotide substitution patterns23 were used to confirm

185

the position of the Mexican sequences based on the consensus clustering patterns observed within the

186

large-scale WG tree, the subsampled WG tree, and the individual large-scale ORF trees, using a

187

bootstrap value >50 for branch support, when possible (SI Table 2). In general, we observed consistency

188

within the global tree and our large-scale and subsampled trees, as depicted by a conserved general

189

structure at an internal branch level. Finally, analysis of the phylogenetic relationship between the

190

Mexican and other viral sequences to identify groups of introduction events (IE) and local transmissions

191

(LT) was done based on the following local definition, in which and IE or LT must include: i) one or more

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

192

Mexican sequences, ii) a minimum of one closest related sister sequence(s), iii) and/or the immediate

193

common ancestor 30,31.

194
195

Mutation identification

196

Snippy32 was used to identify all mutations unique to the Mexican genomes, as compared to the

197

reference genome sequence of isolate Wuhan-Hu-1. The large-scale WG alignment in nucleotides

198

(including UTR and intergenic regions) was used as input for SI Table 4, while the large-scale WG

199

concatenated ORF alignment was used as input for SI Table 5. The frequency and distribution for

200

nucleotide and amino acid changes were determined using a normalized Sequence Logo, implemented

201

by JalView33. Non-conservative amino acid changes were determined based on amino acid properties.

202

Finally, the list of amino acid changes obtained was compared to the list of known sites scored to be

203

evolving under pervasive, episodic or directional positive selection, as tested under several dN/dS

204

models34,35.

205
206

RESULTS AND DISCUSSION

207
208

Multiple introduction events of SARS-CoV-2 variants from two different lineages

209

A total of 17 full viral genome sequences were obtained from selected Mexican samples representing the

210

earliest sampled cases detected in the country (Figure 1). From the epidemiological data associated with

211

the Mexican samples, 15 of the cases corresponded to introduction events from travelers returning from

212

abroad that entered the country through Mexico City airport, with 5 of them then relocating to other places

213

within the country using local transportation (either aerial or terrestrial). Two additional cases reported no

214

travel history (Table 1). Global phylogenetic analysis23 confirmed that 8 Mexican strains (samples 8, 17,

215

19, 24, 27, 28, 30, 31) grouped within the SARS-CoV-2 lineage B (also called lineage S, composed by

216

sequences predominantly from the Americas). The remaining 9 Mexican strains (samples 2, 5, 6, 7, 13,

217

16, 22, 32, and 33) grouped within lineage A2 and subclade A2a (also called lineage G, composed by

218

sequences predominantly from Europe) (Figure 2)36. Both the A2/G and B/S lineages are contemporary,

219

as the estimated date of emergence for lineage B/S is 12/29/2019 (CI: 12/20/2019, 01/03/2020), while for

220

lineage A2/G is 01/18/2020 (CI 01/02/2020, 01/19/2020)23. The collection dates for the Mexican samples

221

that fall within lineage B1 range from 03/04/2020 to 03/15/2020, while those that fall within lineage A2

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

222

range from 02/27/2020 to 03/15/2020, including the strain corresponding to the first reported case in

223

México37 REF (sample 33). This suggests an initial co-circulation of both the A2/G and B/S lineages in

224

Mexico (Figure 2). Viruses belonging to the third lineage reported, V, were not identified in this study.

225

Consensus clustering patterns observed within the large-scale and subsampled trees (SI Table

226

2), showed eight well-supported independent introduction events (IE1, IE3, IE5, IE7, IE9, IE10, IE12 and

227

IE13; Figure 2). For IE2, IE4, IE6 and IE8, we were unable to determine their origins and the immediate

228

phylogenetic relatedness of the Mexican sequences, due to low support values and inconsistent

229

clustering patterns across trees (SI Table 2). The current resolution of phylogenomic analyses is limited

230

by the low diversity of the SARS-CoV-2 virus. Thus, for the characterized Mexican viral strains, we could

231

only determine with confidence the geographical origins at a regional level, rather than at country-level

232

resolution. Altogether, these observations suggest that the virus variants identified in this study were

233

more closely related to virus strains circulating at the time in the USA and Europe rather than in China or

234

South East Asia.

235
236

Evidence for early local transmission

237

Sequences 27 and 31 correspond to two individuals that shared travel history to Vail, CO, USA, and that

238

were in direct contact with case 28 in the return flight to Mexico. Nonetheless, the distribution of sequence

239

28 in an independent group (IE12) in relation to sequences 27 and 31 (Figure 2, SI Table 2), suggests

240

that there were at least two different viral variants co-circulating within this specific location in the USA.

241

On the other hand, sequences 8, 27, 30 and 31 grouped together, representing a local transmission

242

cluster (LT11) (Figure 2). This observation is supported by phylogenetic consistency within our local trees

243

and the global tree23, and a high support value (bs: 100) observed for LT11 in all cases (S1 Table 2,

244

Figure 2). Case 8 corresponds to an individual with no epidemiological relationship or contact with cases

245

27, 30 and 31, and with no travel history. Case 30 had travel history to Madrid, Spain, but no direct

246

exposure with cases 27 and 31. For case 30, the possibility of this person acquiring the virus whilst being

247

abroad cannot be ruled out. However, our analysis shows evidence that this person may have contracted

248

the virus whilst already being in Mexico. Thus, LT11 strongly supports the occurrence of at least one

249

independent local transmission event in Mexico City (case 8), as early as the second week of March.

250
251

Genetic variation within the Mexican viral genomes

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

252

When compared to the Wuhan-Hu-1 reference genome, the Mexican sequences displayed between 4

253

and 10 nucleotide substitutions, and between 1 and 5 amino acid changes. This is consistent with the

254

reported rate of evolution of ~8x10-4 nucleotide substitutions per site per year, equivalent to ~2

255

substitutions per month38,39. Collectively, 46 nucleotide substitutions and 20 amino acid residues were

256

identified within the Mexican viral genomes (SI Table 4 and 5). As expected, the majority of these variants

257

were not conserved through the genomes, and only 15 nucleotide changes and 6 amino acid changes

258

were shared by more than one sequence. These results exclude sequences 6, 13 and 16, which showed

259

a considerably lower coverage and depth when compared to the remaining 14 high-quality viral genomes

260

obtained. Thus, most of the variability observed could be explained by errors introduced during reverse

261

transcription, PCR amplification, sequencing or assembly (SI Table 1 and 4).

262

Consistent with our phylogenomic analysis, all Mexican sequences belonging to lineage A2

263

showed two clade-specific nucleotide substitutions, C241T and A23403G. A23403G results in the

264

D614Ge amino acid change in the Spike protein (Table 2). All lineage A2a sequences (including the

265

Mexican isolates) had the additional nucleotide substitution C14408T, resulting in the amino acid change

266

P314L in Orf1b23. Sequences within lineage B had the nucleotide substitution T28144C rendering the

267

L84S amino acid change in the Orf8 protein. Similarly, lineage B1 sequences also showed the nucleotide

268

substitution C18060T (Table 2). No evidence for recombination was found within any of the alignments, in

269

agreement with previous observations28. Taken together, our results suggest the Mexican viral sequences

270

display the genetic changes according to their phylogenetic placement.

271
272

H49Y amino acid change in Mexican sequences within LT1

273

We further identified within all Mexican sequences grouping with the local transmission cluster (LT11), an

274

H to Y amino acid change in position 49 of the Spike protein, corresponding to the C21707T nucleotide

275

change in the whole genome and nucleotide alignment numbering. H49Y represents a non-conservative

276

mutation located within the N-terminal domain (NTD) of the S glycoprotein trimer40. No evidence of

277

episodic or directional positive selection was found for this site, as tested under several dN/dS

278

models34,35.

279

Mapping this nucleotide change onto the Nextstrain global tree23 with dates ranging from

280

December 2019 to April 2020, revealed that this mutation represents a homoplasy that has occurred with

281

a frequency of 0.4% (20/4533) within the genomes displayed in the global tree as of May 6th 2020. This

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

282

change first occurred in a single cluster of 14 sequences mainly from China (representative sequence:

283

Jiangsu/JS02/2020 EPI ISL 411952). The estimated date of emergence for this cluster that eventually

284

died off (stopped circulating and had no more descendants) was of 01/12/2020 (CI:01/08/2020-

285

01/16/2020). This mutation was detected again in the Mexican sequences in LT11 (Table 1, Figure 2).

286

Since then, the C21707T/H49Y mutation has also appeared independently in three strains from Australia

287

(EPI ISL 426898, EPI_ISL_430632 and EPI_ISL_430633), two strains from the UK (EPI_ISL_433757 and

288

EPI_ISL_432818), one strain from Taiwan (EPI_ISL_417518) and two strains from the USA

289

(EPI_ISL_408010 and EPI_ISL_430050), with collection dates ranging from 01/29/2020 to 04/05/2020

290

(sequences deposited on GISAID platform by May 10th 2020). Of notice, all the sequences displaying the

291

H49Y mutation belong to different viral lineages (either, A2, B1 or others), confirming non-phylogenetic

292

correlation (e.g. founder effect), but rather an independent occurrence. It would be important to follow up

293

the genomic surveillance of homoplasic mutations that keep emerging independently through time and

294

space, either to determine if these are sequencing errors41, or to know if these are real homoplasies that

295

may be associated with changes in biological properties or the virus, such as increased virulence as has

296

been shown for other viruses25. In addition, using H49Y as a molecular marker could be used to follow up

297

any further circulation and spread of these viral variants in Mexico.

298
299

Data Availability

300

The generated sequences SARS-CoV-2 from Mexico can be found in GISAID and in Nextstrain24. The

301

corresponding GISAID accession numbers are listed in Table 1.

302
303

ACKNOWLEDGEMENTS

304

This work was partially supported by grant “Epidemiología genómica de los virus SARS-CoV-2 circulantes

305

en México” from the National Council for Science and Technology (CONACyT)-Mexico to CFA, and by

306

grants from the Mexican Government (Comisión de Equidad y Género de las Legislaturas LX-LXI y

307

Comisión de Igualdad de Género de la Legislatura LXII de la H. Cámara de Diputados de la República

308

Mexicana) to SAR and CB. MEZ is supported by a Leverhulme Trust ECR Fellowship (ECF-2019-542).

309

We thank the “Unidad de Secuenciación Masiva y Bioinformática” of the “Laboratorio Nacional de Apoyo

310

Tecnológico a las Ciencias Genómicas” (CONACyT #260481) for their support in sequencing services.

311

We thank all the staff of the Technological Development and Molecular Research Unit, Virology

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

312

Department, and Sample Control and Services Department at InDRE for their technical assistance. The

313

findings and conclusions in this report are only the responsibility of the authors and do not necessarily of

314

the institutions involved.

315

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

FIGURE LEGENDS
Figure 1. Epidemiological positioning of the SARS-CoV-2 samples from Mexico
Epidemiological curve for the early SARS-CoV-2 epidemic in Mexico, dating from late February until early
April. The rise in cumulative cases is shown in red, whilst the daily incidence is shown with orange bars.
Dates of collection for the samples used in this study are indicted with the black arrows. One arrow might
indicate the collection of more than two samples (dates shown in Table 1).

Figure 2. Phylogenomic positioning of the SARS-CoV-2 strains from Mexico.
RAxML tree estimated from the reduced whole genome alignment built using the concatenated main viral
ORFs, and rooted using the Wuhan-Hu-01 strain. Sequences corresponding to the viral isolates from
Mexico sequenced in this work are shown in red, while the region of origin for the identified closest
related immediate ancestors and/or sister isolates is indicated in black. Support values for the branches
of interest are indicated with numbers next to the branches. The clusters identified in this work
representing introduction events (IE1-IE10 and IE12 and IE13) and the local transmission (LT11) are
shown next to the strain names.

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

REFERENCES
1.

Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Nature 579, 270–273 (2020).

2.

Pinotti, F. et al. Lessons learnt from 288 COVID-19 international cases: importations over time, effect
of interventions, underdetection of imported cases. medRxiv 2020.02.24.20027326 (2020).

3.

auspice. https://nextstrain.org/narratives/ncov/sit-rep/2020-01-23.

4.

Li, Q. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected
Pneumonia. N. Engl. J. Med. 382, 1199–1207 (2020).

5.

Liu, J. et al. Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2,
Shenzhen, China, 2020. Emerg. Infect. Dis. 26, (2020).

6.

[No title].
https://www.gob.mx/cms/uploads/attachment/file/547271/Comunicado_Tecnico_Diario_COVID19_2020.04.18.pdf.

7.

de Salud, S. Sistema Nacional de Vigilancia Epidemiológica. gob.mx
http://www.gob.mx/salud/acciones-y-programas/sistema-nacional-de-vigilancia-epidemiologica.

8.....http://www.censida.salud.gob.mx/descargas/biblioteca/documentos/manual_para_la_toma_envio_y_
recepcion_de_muestras.pdf.
9.

https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2.

10. Taboada, B. et al. Is There Still Room for Novel Viral Pathogens in Pediatric Respiratory Tract
Infections? PLoS One 9, e113570 (2014).
11. Taboada, B. et al. The Geographic Structure of Viruses in the Cuatro Ciénegas Basin, a Unique
Oasis in Northern Mexico, Reveals a Highly Diverse Population on a Small Geographic Scale. Appl.
Environ. Microbiol. 84, (2018).
12. Nextera XT DNA Sample Prep Kit Documentation.
https://support.illumina.com/sequencing/sequencing_kits/nextera_xt_dna_kit/documentation.html.
13. Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data.
https://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
14. Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor.
Bioinformatics 34, i884–i890 (2018).
15. Fu, L., Niu, B., Zhu, Z., Wu, S. & Li, W. CD-HIT: accelerated for clustering the next-generation

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

sequencing data. Bioinformatics 28, 3150–3152 (2012).
16. Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and
web-based tools. Nucleic Acids Res. 41, D590–6 (2013).
17. Bankevich, A. et al. SPAdes: a new genome assembly algorithm and its applications to single-cell
sequencing. J. Comput. Biol. 19, 455–477 (2012).
18. Edgar, R. C. MUSCLE: a multiple sequence alignment method with reduced time and space
complexity. BMC Bioinformatics 5, 1–19 (2004).
19. Rice, P., Longden, I. & Bleasby, A. EMBOSS: The European Molecular Biology Open Software Suite.
Trends Genet. 16, 276–277 (2000).
20. Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post-analysis of large
phylogenies. Bioinformatics 30, 1312–1313 (2014).
21. Wu, F. et al. A new coronavirus associated with human respiratory disease in China. Nature 579,
265–269 (2020).
22. Pond, S. Genomic diversity and divergence of SARS-CoV-2/COVID-19. Observable
https://observablehq.com/@spond/current-state-of-sars-cov-2-evolution (2020).
23. https://nextstrain.org/ncov/global?dmax=2020-04-08.
24. https://nextstrain.org/ncov/global.
25. Escalera-Zamudio, M. et al. Parallel Evolution in the Emergence of Highly Pathogenic Avian
Influenza A Viruses. bioRxiv 370015 (2019) doi:10.1101/370015.
26. Hassan, A. S., Pybus, O. G., Sanders, E. J., Albert, J. & Esbjörnsson, J. Defining HIV-1 transmission
clusters based on sequence data. AIDS 31, 1211–1222 (2017).
27. Kosakovsky Pond, S. L., Posada, D., Gravenor, M. B., Woelk, C. H. & Frost, S. D. W. GARD: a
genetic algorithm for recombination detection. Bioinformatics 22, 3096–3098 (2006).
28. Robertson, D. l. et al. nCoV’s relationship to bat coronaviruses & recombination signals (no snakes) no evidence the 2019-nCoV lineage is recombinant. Virological http://virological.org/t/ncovsrelationship-to-bat-coronaviruses-recombination-signals-no-snakes-no-evidence-the-2019-ncovlineage-is-recombinant/331 (2020).
29. Datamonkey Adaptive Evolution Server. http://datamonkey.org/.
30. Shiino, T. et al. Molecular Evolutionary Analysis of the Influenza A(H1N1)pdm, May–September,
2009: Temporal and Spatial Spreading Profile of the Viruses in Japan. PLoS One 5, e11057 (2010).

bioRxiv preprint doi: https://doi.org/10.1101/2020.05.27.120402; this version posted May 30, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.

31. Baillie, G. J. et al. Evolutionary Dynamics of Local Pandemic H1N1/2009 Influenza Virus Lineages
Revealed by Whole-Genome Analysis. J. Virol. 86, 11–18 (2012).
32. Seemann, T. tseemann/snippy. GitHub https://github.com/tseemann/snippy.
33. Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M. & Barton, G. J. Jalview Version 2—a
multiple sequence alignment editor and analysis workbench. Bioinformatics 25, 1189–1191 (2009).
34. Pond, S. Natural selection analysis of SARS-CoV-2/COVID-19. Observable
https://observablehq.com/@spond/natural-selection-analysis-of-sars-cov-2-covid-19 (2020).
35. Dashboard | SARS-CoV-2 Admin. http://covid19.datamonkey.org/2020/04/01/covid19-analysis.
36. Rambaut, A. et al. A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic
epidemiology. bioRxiv 2020.04.17.046086 (2020) doi:10.1101/2020.04.17.046086.
37. Garcés-Ayala, F. et al. Full Genome Sequence of the first SARS-CoV-2 detected in Mexico. Arch.
Virol. (2020). In press.
38. Bedford, T. et al. Cryptic transmission of SARS-CoV-2 in Washington State. medRxiv
2020.04.02.20051417 (2020).
39. Rambaut, A. et al. Phylodynamic Analysis | 176 genomes | 6 Mar 2020. Virological
http://virological.org/t/phylodynamic-analysis-176-genomes-6-mar-2020/356 (2020).
40. Gui, M. et al. Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a
prerequisite conformational state for receptor binding. Cell Res. 27, 119–129 (2016).
41. http://virological.org/t/issues-with-sars-cov-2-sequencing-data/473.

Figure 1
3000

Number of cases

2500

2000

1500
Cumulative cases

1000

500

Sample collection
Daily Incidence

0

Date of collection

Figure 2
76

IE13

South America
87
17_Mexico/EdoMex-InDRE_03
19_Mexico/Queretaro-InDRE_04

0

Europe
28_Mexico/CDMX-INCMNSZ_02

100
99

8_Mexico/CDMX-INER_05
31_Mexico/CDMX-INCMNSZ_04
30_Mexico/CDMX-INCMNSZ_03
27_Mexico/CDMX-INCMNSZ_01
24_Mexico/CDMX-InDRE_06

1

LT11
IE10

USA

68

42

IE12

IE5

16_Mexico/Chiapas-InDRE_02
Europe

IE6
IE8

33_Mexico/CDMX-InDRE_01
Europe
13_Mexico/Chihuahua-IMSS_01
Europe

84

6_Mexico/CDMX-INER_03
Europe

0

32_Mexico/CDMX-INCMNSZ_05
Australia

56
96

91

IE7

IE3
IE2
IE4
IE1

5_Mexico/CDMX-INER_02
Europe

8

2_Mexico/CDMX-INER_01
Europe
Europe
78
22_Mexico/Puebla-InDRE_05
Europe

Europe
7_Mexico/CDMX-INER_04
Europe

IE9

Wuhan_Hu_1

6.0E-5

Clade
B/S

Clade
A2/G

Table 1. List of viral genomes derived from Mexican samples.

Sample ID

Virus name

Accession
GISAID ID

Location
Country_City

2
5
6
7
8
13
16
17
19
22
24
27
28
30
31
32
33

Mexico/CDMX-INER_01
Mexico/CDMX-INER_02
Mexico/CDMX-INER_03
Mexico/CDMX-INER_04
Mexico/CDMX-INER_05
Mexico/Chihuahua-IMSS_01
Mexico/Chiapas-InDRE_02
Mexico/EdoMex-InDRE_03
Mexico/Queretaro-InDRE_04
Mexico/Puebla-InDRE_05
Mexico/CDMX-InDRE_06
Mexico/CDMX-INCMNSZ_01
Mexico/CDMX-INCMNSZ_02
Mexico/CDMX-INCMNSZ_03
Mexico/CDMX-INCMNSZ_04
Mexico/CDMX-INCMNSZ_05
Mexico/CDMX-InDRE_01

EPI_ISL_424345
EPI_ISL_424348
EPI_ISL_424625
EPI_ISL_424626
EPI_ISL_424627
EPI_ISL_424731
EPI_ISL_424666
EPI_ISL_424667
EPI_ISL_424670
EPI_ISL_424672
EPI_ISL_424673
EPI_ISL_426361
EPI_ISL_426362
EPI_ISL_426363
EPI_ISL_426364
EPI_ISL_426365
EPI_ISL_412972

Mexico_CDMX
Mexico_CDMX
Mexico_CDMX
Mexico_CDMX
Mexico_CDMX
Mexico_Chihuahua
Mexico_Chiapas
Mexico_Edomex
Mexico_Queretaro
Mexico_Puebla
Mexico_CDMX
México_CDMX
México_CDMX
México_CDMX
México_CDMX
México_CDMX
México_CDMX

Age Sex M/F
42
55
29
25
38
21
18
71
43
31
63
70
70
59
71
32
35

M
F
M
F
M
M
F
M
M
M
F
F
M
M
M
M
M

EH Place

Collection
date

Arrival to
Mexico

Port of
Entry

EH_Spain
EH_Spain_France
EH_Spain
EH_Egypt_Barcelona_Spain
EH_None
EH_UK_France_USA
EH_Italy
EH_Italy
EH_Spain_Holand_USA
EH_Spain_France
EH_Denver_USA
EH_Vail_USA
EH_Vail_USA
EH_Madrid_Spain
EH_Vail_USA_Germany
EH_None
EH_Italy

12/03/20
13/03/20
13/03/20
15/03/20
15/03/20
13/03/20
29/02/20
04/03/20
10/03/20
11/03/20
12/03/20
12/03/20
12/03/20
08/03/20
10/03/20
12/03/20
27/02/20

12/03/20
12/03/20
11/03/20
15/03/20
N/A
12/03/20
25/02/20
21/02/20
06/03/20
09/03/20
06/03/20
08/03/20
08/03/20
12/03/20
08/03/20
N/A
N/A

Mexico City
Mexico City
Mexico City
Mexico City
N/A
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
Mexico City
N/A
Mexico City

Table 2. Nucleotide and amino acid changes in the Mexican samples compared to the reference strain Wuhan-Hu-1.

nt change/position in WG nt aln1 vs MN908947
241
14408
18060
23403
28144
MN908947
7_Mexico/CDMX-INER_04
22_Mexico/Puebla-InDRE_05
2_Mexico/CDMX-INER_01
32_Mexico/CDMX-INCMNSZ_05
5_Mexico/CDMX-INER_02
6_Mexico/CDMX-INER_03
13_Mexico/Chihuahua-IMSS_01
33_Mexico/CDMX-InDRE_01
16_Mexico/Chiapas-InDRE_02
27_Mexico/CDMX-INCMNSZ_01
30_Mexico/CDMX-INCMNSZ_03
31_Mexico/CDMX-INCMNSZ_04
8_Mexico/CDMX-INER_05
24_Mexico/CDMX-InDRE_06
28_Mexico/CDMX-INCMNSZ_02
19_Mexico/Queretaro-InDRE_04
17_Mexico/EdoMex-InDRE_03
Lineage defining mutations2

C
U
U
U
U
U
U
U
U
U
.
.
.
.
.
.
.
.
A2/G

C
U
U
U
U
U
U
U
U
N
.
.
.
.
.
.
.
.
A2a

C
.
.
.
.
.
.
.
.
.
U
U
U
U
U
.
.
.
B1

A
G
G
G
G
G
N
G
G
N
.
.
.
.
.
.
.
.
A2/G

U
.
.
.
.
.
.
.
.
N
C
C
C
C
C
C
C
C
B/S

aa change/position in WG ORF concatenated aln1 vs MN908947

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Genome Region
Position in WG concatenated CDS aln1
MN908947
7_Mexico/CDMX-INER_04
22_Mexico/Puebla-InDRE_05
2_Mexico/CDMX-INER_01
32_Mexico/CDMX-INCMNSZ_05
5_Mexico/CDMX-INER_02
6_Mexico/CDMX-INER_03
13_Mexico/Chihuahua-IMSS_01
33_Mexico/CDMX-InDRE_01
16_Mexico/Chiapas-InDRE_02
27_Mexico/CDMX-INCMNSZ_01
30_Mexico/CDMX-INCMNSZ_03
31_Mexico/CDMX-INCMNSZ_04
8_Mexico/CDMX-INER_05
24_Mexico/CDMX-InDRE_06
28_Mexico/CDMX-INCMNSZ_02
19_Mexico/Queretaro-InDRE_04
17_Mexico/EdoMex-InDRE_03
Lineage defining mutations/positions1
Non-conservative amino-acid change 2
Changes observed 2
Frequency3
Evidence for positive selection 4
1

224
T
.
.
.
.
.
.
.
.
.
.
.
.
.
I
.
.
.

Orf1a (1-4405)
892
3071
P
F
L
.
.
.
.
.
.
.
.
.
X
.
.
X
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Y
.
.
.
.

#
T99

*
P99

§
F98 Y2

3606
L
.
.
.
.
.
.
.
.
.
.
.
.
.
F
.
.
.

WS
L83 F15

Orf1b (4406-7000)
4619
5696
5732
P
S
P
L
.
.
L
L
.
L
.
.
L
.
.
L
.
.
L
.
.
L
.
.
L
.
.
X
.
.
.
.
L
.
.
L
.
.
L
.
.
L
.
.
L
.
.
.
.
.
.
.
.
.
A2a (P314L)
WS
L58 P42

†
S99

WS
P87 L12

S (7001-8282)
Orf3 (8505-8779) Orf7a (8780-8900) Orf8 (8901-9021) N (9022-9440)
7058
7623
8700
8817
8984
9225
H
D
G
G
L
G
.
G
.
.
.
.
.
G
.
V
.
.
.
G
.
.
.
.
.
G
.
.
.
.
.
G
.
.
.
.
.
X
.
X
.
X
.
G
.
X
.
R
.
G
.
.
.
R
.
X
.
X
X
R
Y
.
.
.
S
.
Y
.
.
.
S
.
Y
.
.
.
S
.
Y
.
.
.
S
.
.
.
.
.
S
.
.
.
V
.
S
.
.
.
.
.
S
.
.
.
.
.
S
.
H49Y
A2/G (D614G)
B/S (L84S)

H99

WS
Y58 D41

§
G98 V2

Non-conservative amino-acid changes shown in red
Cluster defining homoplassic mutation of the Mexican sequences are shown in black.
Widespread mutations are indicated under WS. Unique changes to the Mexican sequences representing singletons are excluded (extended info avilable in SI Table 5).
#
Shared with USA/WA_UW153/2020|EPI_ISL_416691|2020_03_13
* Shared with England/SHEF_C0707/2020|EPI_ISL_420270|2020_03_22
§ Shared with 45 sequences, mostly from Australia and Spain.
† Shared with 5 sequences from Australia, Portugal, Spain and USA.
‡ Shared with Portugal/PT0024/2020|EPI_ISL_418009|2020_03_15
$
Shared with USA/WA_UW304/2020|EPI_ISL_418872|2020_03_23

4

WS
L82 S17

WS
G83 R16

General lineage defining mutations are shown in blue and orange, as defined in https://nextstrain.org/ncov/global and in GISAID preliminary analysis summary update 2020-04-07 1500UTC. No changes observed in M CDS (8283-8504).

2

3

‡
G99

Frequency of a given aa in percentage observed in the aln. Only changes present in > 1% of the sequences in the aln are shown.
Sites with a dN/dS >1 are shown in green, as compared to the list of sites determined under diverse dN/dS models described in http://covid19.datamonkey.org/2020/04/01/covid19-analysis/

Supplementary Table 1. Sequencing results.

Sample
ID

Virus_name

2
5
6
7
8
13
16
17
19
22
24
27
28
30
31
32
33

Mexico/CDMX-INER_01
Mexico/CDMX-INER_02
Mexico/CDMX-INER_03
Mexico/CDMX-INER_04
Mexico/CDMX-INER_05
Mexico/Chihuahua-IMSS_01
Mexico/Chiapas-InDRE_02
Mexico/EdoMex-InDRE_03
Mexico/Queretaro-InDRE_04
Mexico/Puebla-InDRE_05
Mexico/CDMX-InDRE_06
Mexico/CDMX-INCMNSZ_01
Mexico/CDMX-INCMNSZ_02
Mexico/CDMX-INCMNSZ_03
Mexico/CDMX-INCMNSZ_04
Mexico/CDMX-INCMNSZ_05
Mexico/CDMX-InDRE_01

#

Sample Raw valid
reads
Type#
NPS
NPS
NPS
NPS
NPS
NPS
OPS
NAS
OPS
OPS
OPS
NPS
NPS
NPS
NPS
NPS
NPS

On-target
reads ( %)

13,949,246
12,406 (0.09)
26,958,293
28,208 (0.10)
11,143,321
3,970 (0.04)
10,372,811
21,080 (0.20)
2,274,643
11,648 (0.51)
12,785,238
7,331 (0.06)
4,322,780
1,739 (0.04)
8,173,886
85,170 (1.04)
9,394,551
60,545 (0.64)
5,030,534
39,210 (0.78)
3,890,600
109,000 (2.81)
14,770,367
79,364 (0.54)
2,898,415
21,985 (0.76)
3,956,195
23,550 (0.60)
4,581,562
97,388 (2.13)
2,648,330
7,813 (0.30)
2,662,304 1,000,109 (37.57)

Genome
coverage

Depth

Mean Depth*

99.17
98.56
84.25
99.82
99.73
90.98
83.06
99.90
99.91
99.90
99.92
99.88
99.90
99.91
99.92
99.34
100.00

30
69
9
51
28
18
4
200
145
93
256
164
53
57
228
19
3983

30
70
11
51
28
20
8
200
145
93
256
164
53
57
228
19
3983

Abbreviation: NPS=nasopharyngeal swab, OP= oropharyngeal swab, NAS=nasopharyngeal aspirate
* In relationship to the ratio of unambiguous bases to the reference sequence length (using at least 5 unique reads and 90% agreement during base calling)

Supplementary Table 2. Clustering patterns for the Mexican samples within the reduced and large-scale WG and individual ORF ML trees.
large-scale WG 1

large-scale Orf1a1

large-scale Orf1b1

large-scale S1

IE1-bs 78
22_Mexico/Puebla-InDRE_05/2020|EPI_ISL_424672|Mexico_Puebla|31|M|EH_Spain_France|3_11_2020
Portugal/PT0024/2020|EPI_ISL_418009|PRT_Portugal|Age_29|Sex_F|D0_NA|EH_NA|3_15_2020
Basal--bs 96: Spain/Madrid_H11_40/2020|EPI_ISL_417967|ESP_Madrid|Age_44|Sex_F|D0_NA|EH_NA|3_12_2020

reduced -WG 1

IE1-bs 6
YES

IE1-bs 0
NO

IE1-bs 0
YES

IE1-bs 0
NO-POLYTOMY

IE2-bs 8
32_Mexico/CDMX-INCMNSZ_05/2020|EPI_ISL_426365|Mexico_CDMX|70|F|EH_Vail_USA|3_12_2020
Australia/VIC254/2020|EPI_ISL_419949|AUS_Victoria|Age_67|Sex_M|D0_NA|EH_NA|2020_03_21
Basal--bs 0: Australia/VIC164/2020|EPI_ISL_419861|AUS_Victoria|Age_37|Sex_NA|D0_NA|EH_NA|2020_03_18

IE2-bs 27
YES

IE2-bs 0
NO

IE2-bs 0
NO

IE2-bs 0
NO

IE3-bs 0
5_Mexico/CDMX-INER_02/2020|EPI_ISL_424348|Mexico_CDMX|55|F|EH_Spain_France|3_13_2020
Spain/Madrid_H12_1905/2020|EPI_ISL_421175|ESP_Madrid|Age_25|Sex_F|D0_NA|EH_NA|2020_03_29
Basal-bs: None

IE3-bs 0
YES

IE3-bs 0
NO

IE3-bs 0
YES-POLYTOMY

IE3-bs 0
NO

IE4-bs 56
2_Mexico/CDMX-INER_01/2020|EPI_ISL_424345|Mexico_CDMX|42|M|EH_Spain|3_12_2020
Hungary/2/2020|EPI_ISL_418183|HUN_Baranya|Age_26|Sex_F|D0_H|EH_NA|2020_03_17
Basal--bs 0: None

IE4-bs 61
NO

IE4-bs 0
NO

IE4-bs 0
NO-POLYTOMY

IE4-bs 0
NO

IE5-bs 68
Wales/PHWC_25551/2020|EPI_ISL_421004|GBR_Wales|Age_73|Sex_M|D0_NA|EH_NA|2020_03_23
16_Mexico/Chiapas-InDRE_02/2020|EPI_ISL_424666|Mexico_Chiapas|18|F|EH_Italy|2_29_2020
Basal--bs 0: None

IE5-bs 19
YES

IE5-bs 0
NO

IE5-bs 0
NO

IE5-bs 0
NO-POLYTOMY

IE6-bs 1
NO

IE6-bs 0
NO-POLYTOMY

IE6-bs 0
NO-POLYTOMY

IE6-bs 0
NO-POLYTOMY

IE7-bs 84
6_Mexico/CDMX-INER_03/2020|EPI_ISL_424625|Mexico_CDMX|29|M|EH_Spain|3_13_2020
England/20108034006/2020|EPI_ISL_417258|GBR_England|Age_74|Sex_F|D0_NA|EH_NA|2020_03_06

IE7-bs 67
YES

IE7-bs 0
YES

IE7-bs 27
YES

IE7-bs 0
NO

IE8-bs 42
Italy/TE4959/2020|EPI_ISL_418259|ITA_Abruzzo|Age_76|Sex_M|D0_NA|EH_NA|2020_03_14
13_Mexico/Chihuahua-IMSS_01/2020|EPI_ISL_424731|Mexico_Chihuahua|21|M|EH_UK_France_USA|3_13_2020
Basal--bs 0: None

IE8-bs 18
YES

IE8-bs 0
NO

IE8-bs 0
NO-POLYTOMY

IE8-bs 0
NO-POLYTOMY

IE9-bs 91
7_Mexico/CDMX-INER_04/2020|EPI_ISL_424626|Mexico_CDMX|25|F|EH_Egypt_Barcelona_Spain|3_15_2020
England/SHEF_C0707/2020|EPI_ISL_420270|GBR_England|Age_73|Sex_F|D0_NA|EH_NA|2020_03_22
Basal-bs: None

IE9-bs 79
YES

IE9-bs 0
YES

IE9-bs 0
NO-POLYTOMY

IE9-bs 0
NO

IE10-bs 99
Australia/VIC110/2020|EPI_ISL_419716|AUS_Victoria|Age_62|Sex_F|D0_NA|EH_NA|2020_03_18
24_Mexico/CDMX-InDRE_06/2020|EPI_ISL_424673|Mexico_CDMX|63|F|EH_Denver_USA|3_12_2020

IE10-bs 0
NO

IE10-bs 2
YES

IE10-bs 0
YES-POLYTOMY

IE10-bs 0
YES-POLYTOMY

LT11-bs 100 CLUSTER
31_Mexico/CDMX-INCMNSZ_04/2020|EPI_ISL_426364|Mexico_CDMX|70|M|EH_Vail_USA|3_12_2020
8_Mexico/CDMX-INER_05/2020|EPI_ISL_424627|Mexico_CDMX|38|M|EH_None|3_15_2020
27_Mexico/CDMX-INCMNSZ_01/2020|EPI_ISL_426361|Mexico_CDMX|32|M|EH_None|3_12_2020
30_Mexico/CDMX-INCMNSZ_03/2020|EPI_ISL_426363|Mexico_CDMX|38|M|EH_None|3_12_2020
Basal-bs: None

IE11-bs 98 CLUSTER
YES

C11.1--bs 0
BROKEN CLUSTER

C11.1--bs 0
BROKEN CLUSTER

IE11-bs 89 CLUSTER
YES

IE12-bs 2
28_Mexico/CDMX-INCMNSZ_02/202|EPI_ISL_426362|Mexico_CDMX|71|M|EH_Vail_USA_Germany|3_10_2020
Basal--bs 0: Spain/CastillayLeon201372/2020|EPI_ISL_418249|ESP_Castilla_y_Leon|Age_25|Sex_F|D0_NA|EH_NA|2020_03_03

IE12-bs 0
YES

IE12-bs 0
YES

IE12-bs 0
YES-POLYTOMY

IE12-bs 0
NO

IE13 -bs 87
Chile/Talca_2/2020|EPI_ISL_414578|CHL_Talca|Age_33|Sex_F|D0_NA|EH_NA|2020_03_04
Chile/Talca_1/2020|EPI_ISL_414577|CHL_Talca|Age_33|Sex_M|D0_R|EH_Asia_Europe|2020_03_02
17_Mexico/EdoMex-InDRE_03/2020|EPI_ISL_424667|Mexico_Edomex|71|M|EH_Italy|3_4_2020
Basal-bs 2: 19_Mexico/Queretaro-InDRE_04/2020|EPI_ISL_424670|Mexico_Queretaro|43|M|EH_Spain_Holand_USA|13_10_2020

IE13-bs 0
YES

IE13-bs 0
YES

IE13-bs 33
YES

IE13-bs 0
NO

NO-POLYTOMY-BROKEN CLUSTER WITH 19

NO-POLYTOMY-BROKEN CLUSTER WITH 19

NO

IE6-bs 0
33_Mexico/CDMX-InDRE_01/2020|EPI_ISL_412972|Mexico_CDMX|35|M|EH_Italy|2_27_2020
Basal--bs 1:England/20122119502/2020|EPI_ISL_418681|GBR_England|Age_31|Sex_F|D0_NA|EH_NA|2020_03_17

1

NO-POLYTOMY-BROKEN CLUSTER WITH 19

Consistency for clustering patterns observed within >2 trees and/or bootstrap support values >50 are indicated in red. YES/NO indicates conserved clustering patterns.

Supplementary Table 3. List of sequences and corresponding metadata used for the reduced alignments.
Virus_name
Australia/NSW05/2020
Australia/NSW14/2020
Australia/NSW27/2020
Australia/QLDID919/2020
Australia/VIC110/2020
Australia/VIC123/2020
Australia/VIC128/2020
Australia/VIC130/2020
Australia/VIC134/2020
Australia/VIC138/2020
Australia/VIC154/2020
Australia/VIC163/2020
Australia/VIC164/2020
Australia/VIC177/2020
Australia/VIC194/2020
Australia/VIC20/2020
Australia/VIC204/2020
Australia/VIC213/2020
Australia/VIC222/2020
Australia/VIC226/2020
Australia/VIC228/2020
Australia/VIC244/2020
Australia/VIC249/2020
Australia/VIC254/2020
Australia/VIC256/2020
Australia/VIC274/2020
Australia/VIC278/2020
Australia/VIC293/2020
Australia/VIC299/2020
Australia/VIC300/2020
Australia/VIC304/2020
Australia/VIC60/2020
Australia/VIC68/2020
Australia/VIC69/2020
Australia/VIC79/2020
Australia/VIC82/2020
Austria/CeMM0001/2020
Austria/CeMM0002/2020
Austria/CeMM0009/2020
Austria/CeMM0020/2020
Belarus/ChVir2072/2020
Belgium/BJ_0325181/2020
Belgium/DME_0324135/2020
Belgium/DMM_0325180/2020
Belgium/DRV_0325157/2020
Belgium/DV_0324117/2020
Belgium/DVG_0325146/2020
Belgium/JJC_0325165/2020
Belgium/MNL_0324130/2020
Belgium/RS_030257/2020
Belgium/UGent_11/2020
Belgium/ULG_10028/2020
Belgium/VAG_03013/2020
Belgium/VHV_0324118/2020
Belgium/VLM_03011/2020
Belgium/VPE_030650/2020
Brazil/ES_225/2020
Canada/BC_4078583/2020
Canada/ON_PHL3458/2020
Canada/ON_PHL7590/2020
Canada/ON_PHL8580/2020
Chile/Santiago_op4d1/2020
Chile/Talca_1/2020
Chile/Talca_2/2020
Denmark/SSI_02/2020
Denmark/SSI_04/2020
England/200960041/2020
England/200960515/2020
England/200990723/2020
England/20104035803/2020
England/20108034006/2020
England/20109050706/2020
England/20122074602/2020
England/20122119502/2020
England/20124049402/2020
England/20128035202/2020
England/20139047804/2020
England/20139048804/2020
England/20139055304/2020
England/20139056904/2020
England/20139057004/2020
England/20139060004/2020
England/20139062704/2020
England/SHEF_BFD54/2020
England/SHEF_BFF6D/2020
England/SHEF_C0163/2020
England/SHEF_C0181/2020
England/SHEF_C0585/2020
England/SHEF_C05FE/2020
England/SHEF_C0707/2020
England/SHEF_C07CB/2020
England/Sheff01/2020
England/Sheff02/2020
Finland/FIN03032020B/2020
France/GE1583/2020
France/GE1583/2020
Georgia/Tb_468/2020
Georgia/Tb_537/2020
Georgia/Tb_54/2020
Germany/BavPat3/2020
Germany/NRW_01/2020
Germany/NRW_04/2020
Germany/NRW_09/2020
Germany/NRW_15/2020
Greece/16/2020
Guangzhou/GZMU0031/2020
Hong_Kong/HKPU29_0102/2020
Hong_Kong/HKPU32_0402/2020
Hong_Kong/HKPU40_2801/2020
Hungary/2/2020
Iceland/150/2020
Iceland/189/2020
Iceland/253/2020
Iceland/313/2020
Iceland/314/2020
Iceland/334/2020
Iceland/335/2020
Iceland/38/2020
Italy/INMI3/2020
Italy/TE4959/2020
Japan/DP0236/2020
Japan/DP0457/2020
Japan/DP0588/2020
Japan/DP0699/2020
Japan/DP0743/2020
Japan/DP0880/2020
Japan/UT_NCGM02/2020
Luxembourg/LNS7866283/2020
Netherlands/Limburg_4/2020
Netherlands/NA_23/2020
Netherlands/NoordBrabant_1/2020
Netherlands/NoordBrabant_5/2020
Norway/2090/2020
Panama/328677/2020
Portugal/PT0009/2020
Portugal/PT0024/2020
Senegal/136/2020
Shanghai/SH0012/2020
Shanghai/SH0026/2020
Shanghai/SH0054/2020
Shanghai/SH0056/2020
Shanghai/SH0074/2020
Shanghai/SH0112/2020
Singapore/17/2020
Singapore/25/2020
Singapore/26/2020
Singapore/29/2020
Singapore/3/2020
South_Korea/KUMC01/2020
Spain/Andalucia201617/2020
Spain/CastillaLaMancha201328/2020
Spain/CastillaLaMancha201329/2020
Spain/CastillayLeon201372/2020
Spain/LaRioja201575/2020
Spain/Madrid_H11_40/2020
Spain/Madrid_H12_1502/2020
Spain/Madrid_H12_1804/2021
Spain/Madrid_H12_1905/2020
Spain/Madrid_R5_8/2020
Spain/Madrid201442/2020
Spain/Madrid201738/2020
Spain/Valencia16/2020
Spain/Valencia3/2020
Spain/Valencia5/2020
Spain/Valencia6/2020
Spain/VH000001133/2020
Sweden/01/2020
Switzerland/1000477806/2020
Switzerland/BL0902/2020
Switzerland/GR2988/2020
Switzerland/GR3043/2020
USA/CA_CDPH_UC4/2020
USA/CruiseA_21/2020
USA/RI_0520/2020
USA/RI_0556/2020
USA/TX1/2020
USA/VA_DCLS_0021/2020
USA/WA_UW22/2020
USA/WA_UW349/2020
USA/WI_02/2020
Wales/PHWC_246B9/2020
Wales/PHWC_25551/2020
Wuhan_Hu_1

Accession_ID
EPI_ISL_412975
EPI_ISL_413600
EPI_ISL_417390
EPI_ISL_417031
EPI_ISL_419716
EPI_ISL_419731
EPI_ISL_419730
EPI_ISL_419823
EPI_ISL_419827
EPI_ISL_419834
EPI_ISL_419851
EPI_ISL_419860
EPI_ISL_419861
EPI_ISL_419874
EPI_ISL_419890
EPI_ISL_419741
EPI_ISL_419899
EPI_ISL_419908
EPI_ISL_419917
EPI_ISL_419921
EPI_ISL_419923
EPI_ISL_419939
EPI_ISL_419944
EPI_ISL_419949
EPI_ISL_420036
EPI_ISL_419967
EPI_ISL_419971
EPI_ISL_419984
EPI_ISL_419990
EPI_ISL_419991
EPI_ISL_419995
EPI_ISL_419772
EPI_ISL_419782
EPI_ISL_419783
EPI_ISL_419791
EPI_ISL_419794
EPI_ISL_419654
EPI_ISL_419655
EPI_ISL_419662
EPI_ISL_419673
EPI_ISL_419692
EPI_ISL_420438
EPI_ISL_420392
EPI_ISL_420437
EPI_ISL_420414
EPI_ISL_420374
EPI_ISL_420403
EPI_ISL_420422
EPI_ISL_420387
EPI_ISL_418986
EPI_ISL_419259
EPI_ISL_421202
EPI_ISL_415155
EPI_ISL_420375
EPI_ISL_415153
EPI_ISL_418805
EPI_ISL_415128
EPI_ISL_418824
EPI_ISL_418368
EPI_ISL_418373
EPI_ISL_418330
EPI_ISL_415661
EPI_ISL_414577
EPI_ISL_414578
EPI_ISL_416143
EPI_ISL_416153
EPI_ISL_414008
EPI_ISL_414009
EPI_ISL_414012
EPI_ISL_417238
EPI_ISL_417258
EPI_ISL_417268
EPI_ISL_418676
EPI_ISL_418681
EPI_ISL_418723
EPI_ISL_420477
EPI_ISL_420697
EPI_ISL_420698
EPI_ISL_420715
EPI_ISL_420716
EPI_ISL_420717
EPI_ISL_420731
EPI_ISL_420742
EPI_ISL_416740
EPI_ISL_418313
EPI_ISL_420255
EPI_ISL_420260
EPI_ISL_420247
EPI_ISL_420243
EPI_ISL_420270
EPI_ISL_420158
EPI_ISL_414500
EPI_ISL_414501
EPI_ISL_413603
EPI_ISL_414600
EPI_ISL_414623
EPI_ISL_415643
EPI_ISL_416480
EPI_ISL_415641
EPI_ISL_414521
EPI_ISL_413488
EPI_ISL_414499
EPI_ISL_414509
EPI_ISL_419532
EPI_ISL_418265
EPI_ISL_414687
EPI_ISL_417187
EPI_ISL_417193
EPI_ISL_419215
EPI_ISL_418183
EPI_ISL_417711
EPI_ISL_417709
EPI_ISL_417581
EPI_ISL_417642
EPI_ISL_417643
EPI_ISL_417663
EPI_ISL_417664
EPI_ISL_417672
EPI_ISL_417921
EPI_ISL_418259
EPI_ISL_416585
EPI_ISL_416601
EPI_ISL_416610
EPI_ISL_416617
EPI_ISL_416621
EPI_ISL_416633
EPI_ISL_418809
EPI_ISL_419596
EPI_ISL_414426
EPI_ISL_415480
EPI_ISL_414428
EPI_ISL_414430
EPI_ISL_420153
EPI_ISL_415152
EPI_ISL_417994
EPI_ISL_418009
EPI_ISL_418216
EPI_ISL_416325
EPI_ISL_416335
EPI_ISL_416362
EPI_ISL_416364
EPI_ISL_416377
EPI_ISL_416400
EPI_ISL_418992
EPI_ISL_420102
EPI_ISL_420103
EPI_ISL_420106
EPI_ISL_407988
EPI_ISL_413017
EPI_ISL_419230
EPI_ISL_418245
EPI_ISL_418246
EPI_ISL_418249
EPI_ISL_419234
EPI_ISL_417967
EPI_ISL_421172
EPI_ISL_421174
EPI_ISL_421175
EPI_ISL_417980
EPI_ISL_417010
EPI_ISL_419237
EPI_ISL_419680
EPI_ISL_414598
EPI_ISL_416484
EPI_ISL_416485
EPI_ISL_418860
EPI_ISL_411951
EPI_ISL_413024
EPI_ISL_414021
EPI_ISL_415698
EPI_ISL_415699
EPI_ISL_413561
EPI_ISL_414480
EPI_ISL_419553
EPI_ISL_420795
EPI_ISL_411956
EPI_ISL_419713
EPI_ISL_414591
EPI_ISL_418916
EPI_ISL_416489
EPI_ISL_419440
EPI_ISL_421004
MN908947

Location_Country_City
AUS_New_South_Wales
AUS_New_South_Wales
AUS_New_South_Wales
AUS_Queensland
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUS_Victoria
AUT
AUT_Vienna
AUT_Vienna
AUT
BLR
BEL_Herselt
BEL_Linter
BEL_Grimbergen
BEL_Wanze
BEL_Beersel
BEL_Geraardsbergen
BEL_Tielt_Winge
BEL_Sint_Agatha_Berchem
BEL_Hoegaarden
BEL_Ghent
BEL_ Liege
BEL_Huldenberg
BEL_Tervuren
BEL_Huldenberg
BEL_Deinze
BRA_Espirito_Santo
CAN_British_Columbia
CAN_Ontario
CAN_Ontario
CAN_Ontario
CHL_Santiago
CHL_Talca
CHL_Talca
DNK_Copenhagen
DNK_Copenhagen
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
GBR_England
FIN_Helsinki
FRA_Grand_Est
FRA_Grand_Est
GEO_Tbilisi
GEO_Tbilisi
GEO_Tbilisi
DEU_Bavaria
DEU_North_Rhine_Westphalia
DEU_North_Rhine_Westphalia
DEU_North_Rhine_Westphalia
DEU_Duesseldor
Greece_Athens
CHN
HKG_Hong_Kong
HKG_Hong_Kong
HKG_Hong_Kong
HUN_Baranya
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ISL_Reykjavik
ITA_Rome
ITA_Abruzzo
JPN_Diamond_Princess
JPN_Diamond_Princess
JPN_Diamond_Princess
JPN_Diamond_Princess
JPN_Diamond_Princess
JPN_Diamond_Princess
JPN_Tokyo
LUX_Luxembourg
NLD_Limburg
NLD_Netherlands
NLD_North_Brabant
NLD_North_Brabant
NOR
PAN_Panama_City
PRT_Portugal
PRT_Portugal
SEN_Dakar
CHN_Shanghai
CHN_Shanghai
CHN_Shanghai
CHN_Shanghai
CHN_Shanghai
CHN_Shanghai
SGP_Singapore
SGP_Singapore
SGP_Singapore
SGP_Singapore
SGP_Singapore
KOR_South_Korea
ESP_Andalusia
ESP_Castilla_La_Mancha
ESP_Castilla_La_Mancha
ESP_Castilla_y_Leon
ESP_La_Rioja
ESP_Madrid
ESP_Madrid
ESP_Madrid
ESP_Madrid
ESP_Madrid
ESP_Madrid
ESP_Madrid
ESP_Valencia
ESP_Valencia
ESP_Valencia
ESP_Valencia
ESP_Barcelona
Sweden
CHE_Zurich
CHE_Basel
CHE
CHE
USA_California
USA
USA_Rhode_Island
USA_Rhode_Island
USA_Texas
USA_Virginia
USA_Washington
USA_Illinois
USA_Wisconsin
UK_Wales
GBR_Wales
China_Wuhan

Age_X
Age_43
Age_41
Age_72
Age_63
Age_62
Age_69
Age_27
Age_74
Age_21
Age_79
Age_39
Age_26
Age_37
Age_66
Age_31
Age_NA
Age_69
Age_24
Age_74
Age_67
Age_67
Age_59
Age_58
Age_67
Age_61
Age_80
Age_40
Age_48
Age_74
Age_35
Age_69
Age_42
Age_65
Age_62
Age_37
Age_43
Age_27
Age_73
Age_72
Age_37
Age_NA
Age_85
Age_76
Age_38
Age_29
Age_49
Age_56
Age_91
Age_51
Age_18
Age_64
Age_45
Age_14
Age_38
Age_48
Age_28
Age_37
Age_59
Age_34
Age_70
Age_40
Age_17
Age_33
Age_33
Age_54
Age_49
Age_42
Age_43
Age_54
Age_80
Age_74
Age_59
Age_89
Age_31
Age_78
Age_56
Age_89
Age_61
Age_86
Age_88
Age_88
Age_64
Age_93
Age_45
Age_93
Age_31
Age_53
Age_45
Age_85
Age_73
Age_54
Age_27
Age_26
Age_55
Age_33
Age_36
Age_NA
Age_NA
Age_NA
Age_38
Age_NA
Age_NA
Age_NA
Age_NA
Age_NA
Age_60
Age_91
Age_22
Age_86
Age_26
Age_40
Age_71
Age_17
Age_20
Age_22
Age_68
Age_50
Age_38
Age_32
Age_76
Age_NA
Age_NA
Age_NA
Age_NA
Age_NA
Age_NA
Age_NA
Age_27
Age_NA
Age_NA
Age_NA
Age_NA
Age_NA
Age_40
Age_72
Age_29
Age_51
Age_76
Age_26
Age_39
Age_59
Age_25
Age_33
Age_71
Age_62
Age_62
Age_33
Age_56
Age_NA
Age_NA
Age_76
Age_56
Age_25
Age_57
Age_44
Age_32
Age_47
Age_25
Age_84
Age_58
Age_95
Age_49
Age_89
Age_43
Age_58
Age_74
Age_NA
Age_30
Age_23
Age_55
Age_36
Age_NA
Age_NA
Age_48
Age_17
Age_50
Age_NA
Age_NA
Age_NA
Age_NA
Age_28
Age_73
Age_41

Sex_M/F
Sex_M
Sex_F
Sex_M
Sex_F
Sex_F
Sex_M
Sex_M
Sex_M
Sex_F
Sex_NA
Sex_M
Sex_M
Sex_NA
Sex_M
Sex_M
Sex_NA
Sex_M
Sex_M
Sex_M
Sex_M
Sex_NA
Sex_M
Sex_M
Sex_M
Sex_F
Sex_F
Sex_M
Sex_F
Sex_F
Sex_NA
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_NA
Sex_M
Sex_M
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_M
Sex_F
Sex_F
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_M
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_M
Sex_M
Sex_F
Sex_F
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_M
Sex_M
Sex_M
Sex_M
Sex_F
Sex_F
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_M
Sex_F
Sex_M
Sex_F
Sex_F
Sex_M
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_F
Sex_M
Sex_M
Sex_M
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_M
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_F
Sex_F
Sex_F
Sex_M
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_M
Sex_F
Sex_F
Sex_M
Sex_NA
Sex_F
Sex_M
Sex_M
Sex_F
Sex_M
Sex_F
Sex_F
Sex_F
Sex_F
Sex_M
Sex_F
Sex_M
Sex_F
Sex_M
Sex_M
Sex_M
Sex_M
Sex_NA
Sex_M
Sex_M
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_M
Sex_F
Sex_F
Sex_NA
Sex_NA
Sex_NA
Sex_NA
Sex_M
Sex_M
Sex_M

DO_S/D/NA
D0_R
D0_R
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_D
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_R
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_H
D0_NA
D0_NA
D0_NA
D0_NA
D0_H
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_H
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_A
D0_A
D0_A
D0_A
D0_A
D0_A
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_L
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_H
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
D0_NA
DO_D

EH_Country
EH_Iran
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_Asia_Europe
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_AUS
EH_NA
EH_AUS
EH_AUS
EH_AUS
EH_UK
EH_NA
EH_UK
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_Europe
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_Asia
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_NA
EH_None

Collection_date
2_28_2020
3_3_2020
3_8_2020
3_11_2020
3_18_2020
3_20_2020
3_20_2020
3_21_2020
3_22_2020
2_23_2020
3_17_2020
3_18_2020
3_18_2020
3_18_2020
3_19_2020
3_8_2020
3_19_2020
3_20_2020
3_20_2020
3_20_2020
3_20_2020
3_21_2020
3_21_2020
3_21_2020
3_21_2020
3_22_2020
3_22_2020
3_23_2020
3_23_2020
3_23_2020
3_23_2020
3_13_2020
3_13_2020
3_13_2020
3_14_2020
3_14_2020
3_3_2020
2_26_2020
3_14_2020
3_22_2020
03_2020
3_25_2020
3_24_2020
3_25_2020
3_25_2020
3_24_2020
3_25_2020
3_25_2020
3_24_2020
3_2_2020
3_24_2020
3_30_2020
3_1_2020
3_24_2020
3_3_2020
3_6_2020
2_29_2020
3_3_2020
3_12_2020
3_14_2020
3_5_2020
3_8_2020
3_2_2020
3_4_2020
2_28_2020
3_2_2020
2_27_2020
2_25_2020
2_27_2020
3_3_2020
3_6_2020
3_5_2020
3_10_2020
3_17_2020
3_16_2020
3_18_2020
3_29_2020
3_28_2020
3_29_2020
3_26_2020
3_26_2020
3_28_2020
3_28_2020
3_3_2020
3_24_2020
3_25_2020
3_24_2020
3_25_2020
3_25_2020
3_22_2020
3_28_2020
3_4_2020
3_3_2020
3_3_2020
2_26_2020
2_25_2020
3_10_2020
3_11_2020
2_27_2020
3_2_2020
2_28_2020
2_26_2020
2_28_2020
3_11_2020
3_18_2020
2_25_2020
2_8_2020
2_9_2020
2_10_2020
3_17_2020
3_13_2020
3_16_2020
3_17_2020
3_18_2020
3_18_2020
3_14_2020
3_13_2020
3_16_2020
3_1_2020
3_14_2020
2_16_2020
2_16_2020
2_17_2020
2_17_2020
2_17_2020
2_17_2020
2_1_2020
3_12_2020
3_3_2020
3_9_2020
3_2_2020
3_5_2020
3_16_2020
3_6_2020
3_8_2020
3_15_2020
3_13_2020
2_2_2020
2_2_2020
2_2_2020
2_8_2020
2_7_2020
2_2_2020
2_10_2020
3_5_2020
3_5_2020
3_6_2020
2_1_2020
2_6_2020
3_5_2020
3_1_2020
3_1_2020
3_3_2020
3_3_2020
3_12_2020
3_9_2020
3_29_2020
3_29_2020
3_3_2020
3_4_2020
3_7_2020
3_10_2020
3_5_2020
2_27_2020
2_27_2020
3_15_2020
2_7_2020
2_29_2020
2_27_2020
2_27_2020
2_27_2020
2_27_2020
2_21_2020
2_28_2020
3_1_2020
2_11_2020
3_11_2020
3_6_2020
3_13_2020
3_15_2020
3_17_2020
3_23_2020
12_26_19

Supplementary Table 4. Nucleotide changes within the Mexican samples compared to the reference strain Wuhan-Hu-1. Sequences were order by their philogenetic position in Figure 2.

nt change/position in WG nt aln vs MN908947
3

39

MN908947

T

A

C

Mexico/CDMX-INER

-

.

241
T

823

936

C

C

.

1308

1387

1391

2438

2452

2932

3037

5210

5211

6304

6842

6995

8782

9477

10795

11083

12406

A

C

T

G

A

A

C

C

G

C

T

T

A

C

T

T

G

C

.

.

.

.

.

.

2940
T

T

.

.

.

A

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

.

T

.

.

.

.

.

T

.

.

.

.

N

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

G

.

.

G

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

C

-

.

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

G

.

.

G

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

C

.

.
N

.
N

.
.

.
.

.
C

.
.

T
.

T
T

.
.

.
.

.
.

.
G

.
.

.
.

.
.

.
.

.
.

.
G

.
A

.
N

.
G

.
T

.
A

.
.

G
.

.
.

.
.

G
N

.
N

.
.

.
.

T
.

G
.

.
.

.
.

.
.

A
.

.
.

.
.

.
G

.
N

.
N

.
N

.
.

.
.

.
.

.
.

.
N

.
N

.
N

.
N

.
N

.
.

.
.

N

T

N

N

.

.

.

T

N

N

.

.

.

.

.

.

.

.

.

G

.

.

.

.

.

.

.

G

.

G

.

.

.

.

T

G

N

.

.

.

.

N

.

.

.

.

.

.

.

A

A

C

.

.

.

Mexico/Puebla-InDR

.

.

T

.

.

G

.

.

.

.

.

.

T

.

.

.

Mexico/CDMX-INER

.

.

T

T

.

.

.

.

.

.

.

.

T

.

.

.

exico/CDMX-INCMN

N

.

T

.

.

.

T

.

.

.

.

.

T

.

.

.

Mexico/CDMX-INER
Mexico/CDMX-INER

.
N

.
G

T
T

.
.

.
.

.
N

.
.

.
.

.
A

.
G

.
N

.
N

T
T

.
T

.
T

.
C

exico/Chihuahua-IM

-

-

T

.

.

.

.

N

.

.

T

.

T

.

.

.

14408

14805

14971

16120

16171

17470

C

C

A

G

A

C

17639

17747

17858

18060

18459

18466

18754

18860

19170

19509

19839

C

C

A

C

A

G

C

C

C

G

T

.

.

.

.

.

.
.

.
.

.
.

.
.

.
.

.
.

20268

21707

23280

23403

23422

23751

24694

A

C

C

A

C

C

A

.

.

G

.

.

.

.
G

.

.

G

.

.

.

25156
C
.
.
.

25159

25337

25588

25591

T

G

A

A

.

.

.
.

.

.

.
.

25716

25979

26088

26191

26232

27506

27709

28144

28193

T

G

C

C

T

G

G

T

G

.

C

.

.

T

.
.

.
.

.
.

.

.
.

.
.

28638

28657

28812

28683

28881

28882

28883

C

C

G

C

G

G

G

.

.

.

T

.
.

.
.

.
.

.
.

.
.

29700

29734

29867

A

G

T

.

.

.

G

.
.

.

.
.

Mexico/CDMX-InDR

.

.

T

.

.

.

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

G

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

A

A

C

.

.

.

exico/Chiapas-InD

N

N

T

.

.

.

N

G

.

.

.

.

N

.

.

N

N

N

N

.

.

N

.

N

.

T

A

.

.

.

.

.

.

.

.

N

.

N

.

C

.

.

N

N

.

.

N

.

.

.

N

N

N

.

.

.

.

N

N

N

T

.

.

.

.

A

A

C

.

.

N

exico/CDMX-INCMN
exico/CDMX-INCMN

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

T
T

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

T
T

G
G

T
T

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

T
T

.
.

.
.

T
T

.
.

T
T

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

C
C

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

exico/CDMX-INCMN

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

T

G

T

.

.

.

.

.

.

.

.

T

.

.

T

.

T

.

.

.

.

.

.

.

.

.

.

.

.

C

.

.

.

.

.

.

.

.

.

.

.

Mexico/CDMX-INER

-

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

T

.

.

.

.

.

.

.

.

.

.

.

T

G

T

.

.

.

.

.

.

.

.

T

.

.

T

.

T

.

.

.

.

.

.

.

.

.

.

.

T

C

.

.

.

.

.

.

.

.

.

.

C

Mexico/CDMX-InDR

.

exico/CDMX-INCMN
exico/Queretaro-InD

.
G

exico/EdoMex-InD

.

.
.
.
.

Lineage defining mutations
1

1

.
.
.

.
.
.

T

.

.

.

.

.

.

.

.

.

.

.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

A2

NS

NS

General lineage defining mutations are shown in blue and orange, as defined in https://nextstrain.org/ncov/global. Unique changes identfiied in Nextstrain are marked as NS.

List of total variant sites of the Mexican samples compared to the reference strain Wuhan-1 (MN908947):
Variant sites
Samples
7_Mexico/CDM
22_Mexico/Pue
2_Mexico/CDM
32_Mexico/CDM
5_Mexico/CDM
6_Mexico/CDM
13_Mexico/Chih
33_Mexico/CDM
16_Mexico/Chia
27_Mexico/CDM

7
10
7
8
9
17
13
7
9
8

30_Mexico/CDM
31_Mexico/CDM

8
8

8_Mexico/CDM
24_Mexico/CDM

10
9

28_Mexico/CDM

8

19_Mexico/Que
17_Mexico/Edo

4
4

.

.

T

.

.

.
.

.
.

T
T

A
.

.
.

.

.

T

.

.

NS

.

.

.

.

.

.

.

T

G

.
.

T
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.

.

.

.

.

.

.

T

.

.

.

NS

T

NS

A2a

.
.

.
.
.

T

.

.

.

.

.

.

.

.

.

.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

.
.

T
.

.

.

.

.

.

.

.

.

.

.

.

B1

.

.

.

T

.
.

.
.

.
.

.
.

.

.

.

.

A2

.

.

.

.
.

.
.

.
.

.
.

.

.

.

.

.

NS

.

NS

.
.

.

.

.

.
.

T
.

.
T

.
.

.

.

T

.

NS

.

.

.

.

.
.

.
.

.
.

C
C

.
.

.
.

T
.

.

.

.

.

C

.

.

.

NS

.

.

C

B

.

T

.

.
.

T
.

.
.

.
.

.
.

.
.

.
.

.
.

.

.

.

.

.

.

.

.

NS

.

.

.

.

.

.

Supplementary Table 5. Amino acid changes within the Mexican samples compared to the reference strain Wuhan-Hu-1.
1

Genomic region in WG concatenated ORF aln , site/aa change compared to MN908947
Orf1b (4406-7000)
S (7001-8282)

Orf1a (1-4405)
MN908947
7_Mexico/CDMX-INER_04
22_Mexico/Puebla-InDRE_05
2_Mexico/CDMX-INER_01
32_Mexico/CDMX-INCMNSZ_05
5_Mexico/CDMX-INER_02
6_Mexico/CDMX-INER_03
13_Mexico/Chihuahua-IMSS_01
33_Mexico/CDMX-InDRE_01
16_Mexico/Chiapas-InDRE_02
27_Mexico/CDMX-INCMNSZ_01
30_Mexico/CDMX-INCMNSZ_03
31_Mexico/CDMX-INCMNSZ_04
8_Mexico/CDMX-INER_05
24_Mexico/CDMX-InDRE_06
28_Mexico/CDMX-INCMNSZ_02
19_Mexico/Queretaro-InDRE_04
17_Mexico/EdoMex-InDRE_03
Frequency3
Non-conservative amino-acid change 2
Changes observed 2
Lineage defining mutations2
Evidence for positive selection 4
1

224

889

892

1649

2193

2244

T
.
.
.
.
.
.
.
.
.
.
.
.
.
I
.
.
.
T99

L
.
.
.
.
.
X
F
.
.
.
.
.
.
.
.
.
.
L99

P
L
.
.
.
.
X
.
.
.
.
.
.
.
.
.
.
.
P99

A
.
.
.
.
.
L
.
.
.
.
.
.
.
.
.
.
.
A99

S
T
.
X
.
.
X
X
.
X
.
.
.
.
.
.
.
.
S99

I
.
.
.
.
.
X
F
.
X
.
.
.
.
.
.
.
.
I99

#

*

NS

3071

3606

F
L
.
.
.
.
.
.
.
.
.
.
.
.
X
.
.
.
.
.
.
.
.
.
.
.
.
.
.
F
Y
.
.
.
.
.
F98 Y2 L83 F15
§

WS NS

4619

5190

5207

5696

P
L
L
L
L
L
L
L
L
X
.
.
.
.
.
.
.
.
L58 P42

E
.
.
.
.
.
.
.
.
K
.
.
.
.
.
.
.
.
E99

N
.
.
.
.
.
D
.
.
.
.
.
.
.
.
.
.
.
N99

S
.
L
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
S99

WS
A2a (P314L)

†

5732

5769

P
Y
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
L
C
L
C
L
C
L
C
L
C
.
.
.
.
.
.
P87 L12 Y86 C13
WS

Orf8 (8901-9021)

7058

7582

7623

7739

8208

8268

8571

8700

8771

8817

8885

8984

A
.
.
.
.
.
G
.
.
.
.
.
.
.
.
.
.
.
A99

H
.
.
.
.
.
.
.
.
.
Y
Y
Y
Y
.
.
.
.
H99

T
.
.
.
.
.
.
.
.
X
.
.
.
.
.
I
.
.
T99

D
G
G
G
G
G
X
G
G
X
.
.
.
.
.
.
.
.
Y58 D41

S
.
.
.
.
.
.
C
.
.
.
.
.
.
.
.
.
.
S99

D
.
.
.
.
E
.
.
.
.
.
.
.
.
.
.
.
.
D99

D
.
.
.
Y
.
.
.
.
.
.
.
.
.
.
.
.
.
D99

K
.
.
.
.
.
.
E
.
X
.
.
.
.
.
.
.
.
K99

G
.
.
.
.
.
.
.
.
.
.
.
.
.
.
V
.
.
G98 V2

P
.
.
.
.
.
A
.
.
.
.
.
.
.
.
.
.
.
P99

G
.
V
.
.
.
X
X
.
X
.
.
.
.
.
.
.
.
G99

A
.
.
.
.
.
X
.
.
X
.
.
.
S
.
.
.
.
A99

L
.
.
.
.
.
.
.
.
X
S
S
S
S
S
S
S
S
L82 S18

NS

$

WS

WS
A2/G (D614G)

General lineage defining mutations are shown in blue and orange, as defined in https://nextstrain.org/ncov/global and in GISAID preliminary analysis summary update 2020-04-08 1500UTC. No changes observed in M CDS (8283-8504).

Non-conservative amino-acid changes shown in red
Cluster defining homoplassic mutation of the Mexican sequences are shown in black.
Widespread mutations are indicated under WS. Mutations also in Nexstrain are marked as NS. Unique changes to the Mexican sequences representing singletons are shown in gray.
#
Shared with USA/WA_UW153/2020|EPI_ISL_416691|2020_03_13
* Shared with England/SHEF_C0707/2020|EPI_ISL_420270|2020_03_22
§ Shared with 45 sequences, mostly from Spain.
† Shared with 5 sequences from Australia, Portugal, Spain and USA.
‡ Shared with Portugal/PT0024/2020|EPI_ISL_418009|2020_03_15
$
USA/WA_UW304/2020|EPI_ISL_418872|2020_03_23
4

Orf7a (8780-8900)

6103

P
.
.
.
.
.
X
A
.
X
.
.
.
.
.
.
.
.
P99

2

3

Orf3 (8505-8779)

6068

Frequency of a given aa in percentage observed in the aln. Only changes present in > 1% of the sequences in the aln are shown.
Sites with a dN/dS >1 are shown in green, as compared to the list of sites determined under diverse dN/dS models described in http://covid19.datamonkey.org/2020/04/01/covid19-analysis/

§

‡

WS
B/S (L84S)

N (9022-9440)
9224

9225

R
G
.
.
.
.
.
.
.
.
.
.
X
X
K
R
K
R
K
R
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
R83 K16 G83 R16
WS

WS

